| Dr Victor Luis Perez Labiosa, MD | |
|
617 Calle Manuel Pavia, Santurce, PR 00909 | |
| (787) 727-5381 | |
| Not Available |
| Full Name | Dr Victor Luis Perez Labiosa |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 16 Years |
| Location | 617 Calle Manuel Pavia, Santurce, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538324405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | 20575 (Puerto Rico) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 20575 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Pavia Santurce | Fernandez juncos, PR | Hospital |
| Auxilio Mutuo Hospital | Hato rey, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| M And P Radiologos, Llc | 1254397094 | 16 |
| Oncology And Body Imaging Psc | 1557790110 | 11 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced three new high-capacity, high-efficiency 4 µm particle-size capillary IC columns that enable faster, more accurate analyses.
Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.
Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
› Verified 4 days ago
| Entity Name | M & P Radiologos, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043287055 PECOS PAC ID: 1254397094 Enrollment ID: O20041203000529 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced three new high-capacity, high-efficiency 4 µm particle-size capillary IC columns that enable faster, more accurate analyses.
Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.
Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
› Verified 4 days ago
| Entity Name | Oncology & Body Imaging Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699309161 PECOS PAC ID: 1557790110 Enrollment ID: O20200402000048 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced three new high-capacity, high-efficiency 4 µm particle-size capillary IC columns that enable faster, more accurate analyses.
Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.
Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Luis Perez Labiosa, MD 617 Calle Manuel Pavia, Santurce, PR 00909 Ph: (787) 727-5381 | Dr Victor Luis Perez Labiosa, MD 617 Calle Manuel Pavia, Santurce, PR 00909 Ph: (787) 727-5381 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced three new high-capacity, high-efficiency 4 µm particle-size capillary IC columns that enable faster, more accurate analyses.
Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.
Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
› Verified 4 days ago
Dr. Manuel R. Perez-gonzalez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 617 Calle Dr Pavia Fernandez, Santurce, PR 00909 Phone: 787-727-5381 Fax: 787-728-1477 | |
Dr. Carmen Rosa Alvarez-villar, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1450 Ave Ashford, Cond. Casa Del Valle Suite 1c Condado, Santurce, PR 00907 Phone: 787-723-4664 Fax: 787-722-8495 | |
Martin I Gorrochategui, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1760 Calle Loiza, Ste 205, Santurce, PR 00911 Phone: 305-297-4377 |